3Honerjager P. pharmacology of bipyridine phosphodi- esterase Ⅲ inhibitors [J]. Am Heart J, 1991, 121 (6pt2):1 939-1 944.
4Yamaura K,Okamoto H,Akiyoshi K,et al. Effect of low. dose milrinone on gastri intramueosal pH and systemic inflammation after hypothermic cardiopulmonary bypass[J]. J Cardiothorae Vase Anesh ,2001, 15(2) :197-203.
5Sulek C A,Blas M L,I.obato E B. Milrinone increase milddle cerebral artery blood flow velocity after car- diopulmonary bypass [ J ]. J Cardiothorac Vasc Anesth, 2002,16 ( 1 ) : 64-69.
6Mounoff T,Loiek H M ,VanAken H,et al. Milrinone modnlates endoto xemia systemic inflammation and subsequent alate phase response after cardiopulmonary bypass (CPB) [J]. Anesthesiology, 1999,90 (1) :72-80.
7Cusik D A,Pfeifer P B,Leuigg R J. Effects of in travenons milrinone followed by titration of gigh-chose and vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failare[J]. Am J Cardiol,1998,82(9):1 060-1 065.
8Hatziacharias A, Makris T, Krespi P,et al. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure [J]. Am Heart J,1999,138(2Pt1):241-246.
9[1]Honerjager P. Pharmacology of bipyridine phosphodiesterase Ⅱ inhibitors. Am Heart J, 1991,121:1939
10[2]Shipley JB, Tolman D, Haotills A, et al. Ailribobe:basic and clinical pharmacology and acute and chronic mamagement. Am J Med Sci, 1996,311(6):286
